Outcomes | FBG/HbA1c | n | Events, n (%) | Crude OR (95% CI) | p Value | Adjusted OR (95% CI)a | p Value |
---|---|---|---|---|---|---|---|
Primary Outcomes | |||||||
 All-cause death at 3 months | Q1 (≤ 0.81) | 214 | 2 (0.9) | Ref |  | Ref |  |
Q2 (0.82–0.91) | 212 | 6 (2.8) | 3.09 (0.62–15.48) | 0.170 | 2.86 (0.54–15.24) | 0.218 | |
Q3 (0.92–1.06) | 210 | 10 (4.8) | 5.30 (1.15–24.49) | 0.033 | 3.95 (0.81–19.35) | 0.090 | |
Q4 (≥ 1.07) | 210 | 17 (8.1) | 9.34 (2.13–40.94) | 0.003 | 5.16 (1.03–25.74) | 0.045 | |
 All-cause death at 12 months | Q1 (≤ 0.81) | 183 | 11 (6.0) | Ref |  | Ref |  |
Q2 (0.82–0.91) | 189 | 22 (11.6) | 2.06 (0.97–4.38) | 0.060 | 2.47 (1.09–5.59) | 0.030 | |
Q3 (0.92–1.06) | 190 | 17 (8.9) | 1.54 (0.70–3.38) | 0.285 | 1.31 (0.56–3.07) | 0.534 | |
Q4 (≥ 1.07) | 181 | 35 (19.3) | 3.78 (1.84–7.64) |  < 0.001 | 2.59 (1.14–5.89) | 0.024 |